DNA methylation biomarkers in serum for gastric cancer screening

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 11, 2010, Pages 1034-1038

  Ye, Ting ^a   Chen, Yingxuan ^a   Fang, Jingyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; DNA methylation; Gastric cancer; Proto oncogene; Serum; Tumor suppressor gene

Indexed keywords

ACTIN BINDING PROTEIN; APC PROTEIN; BRCA1 PROTEIN; CADHERIN; CELL PROTEIN; CYCLOOXYGENASE 2; DEATH ASSOCIATED PROTEIN KINASE; DEATH RECEPTOR 4; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN BTG4; PROTEIN FLNC; PROTEIN MAL; PROTEIN MLH1; PROTEIN P15; PROTEIN P16; PROTEIN PATCHED 1; PROTEIN PCDH10; PROTEIN ZIC1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; SECRETED FRIZZLED RELATED PROTEIN 2; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR RUNX3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RELAPSE; CANCER SCREENING; CANCER SURVIVAL; DNA METHYLATION; GENE MUTATION; HUMAN; METASTASIS; ONCOGENE C H RAS; ONCOGENE C MYC; PROGNOSIS; PROTO ONCOGENE; RISK ASSESSMENT; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 77956621806     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557511009011034     Document Type: Article

References (48)

1. Hosoya, K.; Yamashita, S.; Ando, T.; Nakajima, T.; Itoh, F.; Ushijima, T. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis., Cancer Lett., 2009, 285(2), 182-9.
2. Ye, M.; Xia, B.; Guo, Q.; Zhou, F.; Zhang, X. Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. BMC. Cancer, 2007, 7,120-126.
3. Kang, G.H.; Lee, S.; Kim, J.S.; Jung, H.Y. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab. Invest., 2003, 83, 635-641.
4. de Maat, M.F.; van de Velde, C.J.; Umetani, N.; de Heer, P.; Putter, H.; van Hoesel, A.Q.; Meijer, G.A.; van Grieken, N.C.; Kuppen, P.J.; Bilchik, A.J.; Tollenaar, R.A.; Hoon, D.S. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J. Clin. Oncol., 2007, 25, 4887-4894.
5. Maier, S.; Dahlstroem, C.; Haefliger, C.; Plum, A.; Piepenbrock, C. Identifying DNA Methylation Biomarkers of Cancer Drug Response. J. Pharmacogenomics, 2005, 5, 223-232.
6. Graziano, F.; Humar, B.; Guilford, P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann. Oncol., 2003, 14, 1705-1713.
7. Gu, P.; Xing, X.; Tänzer, M.; Röcken, C.; Weichert, W.; Ivanauskas, A.; Pross, M.; Peitz, U.; Malfertheiner, P.; Schmid, R.M.; Ebert, M.P. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia, 2008, 10, 563-572.
8. Chan, A.W.; Chan, M.W.; Lee, T.L.; Ng, E.K.; Leung, W.K.; Lau, J.Y.; Tong, J.H.; Chan, F.K.; To, K.F. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer. Oncol. Rep., 2005, 13, 937-941.
9. Kang, G.H.; Shim, Y.H.; Jung, H.Y.; Kim, W.H.; Ro, J.Y.; Rhyu, M.G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res., 2001, 61, 2847-2851.
10. Zhang, Y.; Qu, X.; Jing, W.; Hu, X.; Yang, X.; Hou, K.; Teng, Y.; Zhang, J.; Liu, Y. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Anticancer Drugs, 2009, 20, 208-214.
11. Ksiaa, F.; Ziadi, S.; Amara, K.; Korbi, S.; Trimeche, M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clin. Chim. Acta., 2009, 404, 128-133.
12. Dong, W.; Tu, S.; Xie, J.; Sun, P.; Wu, Y.; Wang, L. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochem. Biophys. Res. Commun., 2009, 387, 132-138.
13. Wang, L.J.; Jin, H.C.; Wang, X.; Lam, E.K.; Zhang, J.B.; Liu, X.; Chan, F.K.; Si, J.M.; Sung, J.J. ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem. Biophys. Res. Commun., 2009, 379, 959-963.
14. Bernal, C.; Vargas, M.; Ossandón, F.; Santibáñez, E.; Urrutia, J.; Luengo, V.; Zavala, L.F.; Backhouse, C.; Palma, M.; Argandoña, J.; Aguayo, F.; Corvalán, A. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Biol. Res., 2008, 41, 303-315.
15. Du, P.; Ye, H.R.; Gao, J.; Chen, W.; Wang, Z.C.; Jiang, H.H.; Xu, J.; Zhang, J.W.; Zhang, J.C.; Cui, L. Methylation of PTCH1a gene in a subset of gastric cancers. World J. Gastroenterol., 2009, 15, 3799-3806.
16. Gao, Y.J.; Xin, Y.; Zhang, J.J.; Zhou, J. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma. World J. Gastroenterol., 2008, 14, 5000-5007.
17. Kitamura, Y.H.; Shirahata, A.; Sakata, M.; Goto, T.; Mizukami, H.; Saito, M.; Ishibashi, K.; Kigawa, G.; Nemoto, H.; Sanada, Y.; Hibi, K. Frequent methylation of Vimentin in well-differentiated gastric carcinoma. Anticancer Res., 2009, 29, 2227-9.
18. Kim, J.H.; Jung, E.J.; Lee, H.S.; Kim, M.A.; Kim, W.H. Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol. Rep., 2009, 21, 1251-1259.
19. Lee, K.H.; Lim, S.W.; Kim, H.G.; Kim, D.Y.; Ryu, S.Y.; Joo, J.K.; Kim, J.C.; Lee, J.H. Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma. Langenbecks. Arch. Surg., 2009, 394, 661-670.
20. Shapiro, B.; Chakrabarty, M.; Cohn, E.M.; Leon, S.A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer, 1983, 51, 2116-2120.
21. Jahr, S.; Hentze, H.; Englisch, S.; Hardt, D.; Fackelmayer, F.O.; Hesch, R.D.; Knippers, R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res., 2001, 61, 1659-1665.
22. Camps, C.; Sirera, R.; Bremnes, R.; Blasco, A.; Sancho, E.; Bayo, P.; Safont, M.J.; Sanchez, J.J.; Taron, M.; Rosell, R. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? Lung Cancer, 2005, 50, 339-346.
23. Gotoh, T.; Hosoi, H.; Iehara, T.; Kuwahara, Y.; Osone, S.; Tsuchiya, K.; Ohira, M.; Nakagawara, A.; Kuroda, H.; Sugimoto, T. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J. Clin. Oncol., 2005, 23, 5205-5210.
24. Cuda, G.; Gallelli, A.; Nistico, A.; Tassone, P.; Barbieri, V.; Tagliaferri, P.S.; Costanzo, F.S.; Tranfa, C.M.; Venuta, S. Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis? Lung Cancer, 2000, 30, 211-214.
25. Nawroz-Danish, H.; Eisenberger, C.F.; Yoo, G.H.; Wu, L.; Koch, W.; Black, C.; Ensley, J.F.; Wei, W.Z.; Sidransky, D. Microsatellite analysis of serum DNA in patients with head and neck cancer. Int. J. Cancer, 2004, 111, 96-100.
26. Fujiwara, K.; Fujimoto, N.; Tabata, M.; Nishii, K.; Matsuo, K.; Hotta, K.; Kozuki, T.; Aoe, M.; Kiura, K.; Ueoka, H.; Tanimoto, M. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin. Cancer Res., 2005, 11, 1219-1225.
27. Lee, T.L.; Leung, W.K.; Chan, M.W.; Ng, E.K.; Tong, J.H.; Lo, K.W.; Chung, S.C.; Sung, J.J.; To, K.F. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin. Cancer Res., 2002, 8, 1761-1766.
28. Wang, Y.C.; Yu, Z.H.; Liu, C.; Xu, L.Z.; Yu, W.; Lu, J.; Zhu, R.M.; Li, G.L.; Xia, X.Y.; Wei, X.W.; Ji, H.Z.; Lu, H.; Gao, Y.; Gao, W.M.; Chen, L.B. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J. Gastroenterol., 2008, 14, 3074-3080.
29. Ushijima, T.; Sasako, M. Focus on gastric cancar. Cancer Cell, 2004, 5, 121-125.
30. Koike, H.; Ichikawa, D.; Ikoma, H.; Otsuji, E.; Kitamura, K.; Yamagishi, H. Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients. J. Surg. Oncol., 2004, 87, 182-186.
31. Koike, H.; Ichikawa, D.; Ikoma, H.; Tani, N.; Ikoma, D.; Otsuji, E.; Okamoto, K.; Ueda, Y.; Kitamura, K.; Yamagishi, H. Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepatogastroenterology, 2005, 52, 1293-1296.
32. Ichikawa, D.; Koike, H.; Ikoma, H.; Ikoma, D.; Tani, N.; Otsuji, E.; Kitamura, K.; Yamagishi, H. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Anticancer Res, 2004, 24, 2477-2481.
33. Ikoma, H.; Ichikawa, D.; Daito, I.; Nobuyuki, T.; Koike, H.; Okamoto, K.; Ochiai, T.; Ueda, Y.; Yamagishi, H.; Otsuji, E. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer. Hepatogastroenterology, 2007, 54, 946-950.
34. Tani, N.; Ichikawa, D.; Ikoma, D.; Ikoma, H.; Sai, S.; Tomita, H.; Okamoto, K.; Kikuchi, S.; Fujiwara, H.; Ochiai, T.; Ueda, Y.; Otsuji, E.; Hagiwara, A.; Yamagishi, H. An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy. Gan. To. Kagaku. Ryoho., 2006, 33, 1720-1722.
35. Abbaszadegan, M.R.; Moaven, O.; Sima, H.R.; Ghafarzadegan, K.; A'rabi, A.; Forghani, M.N.; Raziee, H.R.; Mashhadinejad, A.; Jafarzadeh, M.; Esmaili-Shandiz, E.; Dadkhah, E. p16 promoter hypermethylation: A useful serum marker for early detection of gastric cancer. World J. Gastroenterol., 2008, 14, 2055-2060.
36. Leung, W.K.; To, K.F.; Chu, E.S.; Chan, M.W.; Bai, A.H.; Ng, E.K.; Chan, F.K.; Sung, J.J. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br. J. Cancer, 2005, 92, 2190-2194.
37. Sakakura, C.; Hamada, T.; Miyagawa, K.; Nishio, M.; Miyashita, A.; Nagata, H.; Ida, H.; Yazumi, S.; Otsuji, E.; Chiba, T.; Ito, K.; Ito, Y. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res., 2009, 29, 2619-2625.
38. Bernal, C.; Aguayo, F.; Villarroel, C.; Vargas, M.; Díaz, I.; Ossandon, F.J.; Santibáñez, E.; Palma, M.; Aravena, E.; Barrientos, C.; Corvalan, A.H. Reprimo as a potential biomarker for early detection in gastric cancer. Clin. Cancer Res., 2008, 14, 6264-9.
39. Leung, W.K.; Man, E.P.; Yu, J.; Go, M.Y.; To, K.F.; Yamaoka, Y.; Cheng, V.Y.; Ng, E.K.; Sung, J.J. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin. Cancer Res., 2006, 12, 3216-21.
40. Cheng, Y.Y.; Yu, J.; Wong, Y.P.; Man, E.P.S.; To, K.F.; Jin, V.X.; Li, J.; Tao, Q.; Sung, J.J.Y.; Chan, F.K.L.; Leung, W.K. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br. J. Cancer, 2007, 97, 895-901.
41. Buffart, T.E.; Overmeer, R.M.; Steenbergen, R.D.; Tijssen, M.; van Grieken, N.C.; Snijders, P.J.; Grabsch, H.I.; van de Velde, C.J.; Carvalho, B.; Meijer, G.A. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br. J. Cancer, 2008, 99, 1802-1807.
42. Yu, J.; Cheng, Y.Y.; Tao, Q.; Cheung, K.F.; Lam, C.N.; Geng, H.; Tian, L.W.; Wong, Y.P.; Tong, J.H.; Ying, J.M.; Jin, H.; To, K.F.; Chan, F.K.; Sung, J.J. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology, 2009,136, 640-651.
43. Graziano, F.; Arduini, F.; Ruzzo, A.; Bearzi, I.; Humar, B.; More, H.; Silva, R.; Muretto, P.; Guilfurd, P.; Testa, E.; Mari, D.; Magnani, M.; Cascinu, S. Prognostic analysis of E-Cadherin gene promoter hypermethylation in patients with surgically resected, nodeYe et al. positive, diffuse gastric cancer. Clin. Cancer Res., 2004, 10, 2784-2789.
44. House, M.G.; Guo, M.; Efron, D.T.; Lillemoe, K.D.; Cameron, J.L.; Syphard, J.E.; Hooker, C.M.; Abraham, S.C.; Montgomery, E.A.; Herman, J.G.; Brock, M.V. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behaviour. J. Gastrointest. Surg., 2003, 7, 1001-1014.
45. Herman, J.G.; Graff, J.R.; Myohanen, S.; Nelkin, B.D.; Baylin, S.B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 1996, 93, 9821-9826.
46. Kaneda, A.; Kaminishi, M.; Yanagihara, K.; Sugimura, T.; Ushijima, T. Identification of silencing of nine genes in human gastric cancers. Cancer Res., 2002, 62, 6645-6650.
47. Duffy, M.J.; Napieralski, R.; Martens, J.W.; Span, P.N.; Spyratos, F.; Sweep, F.C.; Brunner, N.; Foekens, J.A.; Schmitt, M. EORTC PathoBiology Group. Methylated genes as new cancer biomarkers. Eur. J. Cancer, 2009, 45, 335-46.
48. Watanabe, Y.; Kim, H.S.; Castoro, R.J.; Chung, W.; Estecio, M.R.; Kondo, K.; Guo, Y.; Ahmed, S.S.; Toyota, M.; Itoh, F.; Suk, K.T.; Cho, M.Y.; Shen, L.; Jelinek, J.; Issa, J.P. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology, 2009, 136, 2149-2158.